Indevus Pharmaceuticals Inc.
(NASDAQ:IDEV)|
2.32 0.00 (0.00%) Dec 04 - Close |
|
|
|
After-Hours 2.33 +0.01 (0.43%) Thu, 4 Dec 2008 7:40 PM
- Compare IDEV with:
- View: Line | Candlestick
Company Profile
Indevus Pharmaceuticals Inc.
33 Hayden Avenue
Lexington, MA 02421-7966
United States - Map
Phone: (781) 861-8444
Fax: (781) 861-3830
Website: www.interneuron.com
State of incorporation: Delaware
CEO: Dr. Glenn L. Cooper, M.D.
Employees: 251
Sector: Healthcare
Industry Group: Drugs
Industry: Biotechnology
Res/dev/mkt innovative pharmaceuticals
The Company is engaged in the acquisition, development and commercialization of products to treat conditions in urology and endocrinology.
Recent news for IDEV
-
EDGAR Online - Dec 02 at 12:00 ET
-
New Star Analyst Rankings for Indevus Pharmaceuticals Inc.
StarMine - Nov 26 at 9:29 ET
-
Movers roundup: ConAgra, Ariba
AP - Nov 25 at 2:45 ET
-
Indevus Pharmaceuticals, Inc. F4Q08 (Qtr End 09/30/08) Earnings Call Transcript
Seeking Alpha - Nov 25 at 2:24 ET
-
Indevus shares jump on prospects for drug filing
AP - Nov 25 at 12:34 ET
-
Indevus Pharmaceuticals, Inc. Earnings Call scheduled for 9:00 am ET today
CCBN - Nov 25 at 9:00 ET
-
InPlay: Indevus Pharm misses by $0.04, beats on revs
Briefing.com - Nov 25 at 7:49 ET
-
Indevus Pharmaceuticals Announces Fiscal 2008 Year End and Fourth Quarter Results
PR Newswire - Nov 25 at 7:40 ET
-
Q4 2008 Indevus Pharmaceuticals, Inc. Earnings Release - Before Market Open
CCBN - Nov 25 at 7:07 ET
-
FDA Involvement in Biotechnology Sector Discussed in Wall Street Transcript Report
Wall Street Transcript - Nov 19 at 9:12 ET
Top members owning IDEV
-
Top 4%
-39.35%3m:
-39.35%YTD:
-
Top 69%
-41.98%3m:
-41.98%YTD: